These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 5785951)

  • 21. Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.
    Pappagianis D; Zimmer BL; Theodoropoulos G; Plempel M; Hector RF
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1132-8. PubMed ID: 2393272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal action of rifampin.
    Medoff G
    Rev Infect Dis; 1983; 5 Suppl 3():S614-9. PubMed ID: 6356283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic.
    Takesako K; Kuroda H; Inoue T; Haruna F; Yoshikawa Y; Kato I; Uchida K; Hiratani T; Yamaguchi H
    J Antibiot (Tokyo); 1993 Sep; 46(9):1414-20. PubMed ID: 8226319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous infection with Blastomyces dermatitidis and Cryptococcus neoformans.
    Mounts A; Deepe GS
    Med Mycol; 1998 Feb; 36(1):47-50. PubMed ID: 9776812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community-acquired fungal pneumonia in children.
    Maxson S; Jacobs RF
    Semin Respir Infect; 1996 Sep; 11(3):196-203. PubMed ID: 8883177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-dose AmBisome (Liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis.
    Garcia A; Adler-Moore JP; Proffitt RT
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2327-32. PubMed ID: 10952575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of some human pathogenic yeasts and systemic fungi to myxin.
    Sekhon AS; Hargesheimer E
    J Clin Pathol; 1975 Jul; 28(7):547-9. PubMed ID: 1171116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current therapy of pulmonary and disseminated fungal diseases.
    Stamm AM; Dismukes WE
    Chest; 1983 Jun; 83(6):911-7. PubMed ID: 6303713
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species.
    Zhanel GG; Karlowsky JA; Harding GA; Balko TV; Zelenitsky SA; Friesen M; Kabani A; Turik M; Hoban DJ
    Antimicrob Agents Chemother; 1997 Apr; 41(4):863-5. PubMed ID: 9087508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphotericin B lipid complex therapy of experimental fungal infections in mice.
    Clark JM; Whitney RR; Olsen SJ; George RJ; Swerdel MR; Kunselman L; Bonner DP
    Antimicrob Agents Chemother; 1991 Apr; 35(4):615-21. PubMed ID: 2069367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphotericin pharmacophobia.
    Symmers WS
    Br Med J; 1973 Nov; 4(5890):460-3. PubMed ID: 4758449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of experimental systemic mycoses with BRL 49594A.
    Najvar LK; Luther MF; Graybill JR
    J Antimicrob Chemother; 1995 Dec; 36(6):1005-1011. PubMed ID: 8821599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses.
    Fass RJ; Perkins RL
    Ann Intern Med; 1971 Apr; 74(4):535-9. PubMed ID: 5551162
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of formalin on the survival of systemic fungi in tissue.
    Fahmy A; Flournoy DJ; Stewart CV
    Mycopathologia; 1983 Jun; 82(3):175-8. PubMed ID: 6350884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
    Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hamycin: chemotherapeutic studies in systemic mycoses of man.
    Utz JP; Witorsch P; Williams TW; Emmons CW; Shadomy HJ; Piggott W
    Am Rev Respir Dis; 1967 Mar; 95(3):506-9. PubMed ID: 6018710
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
    De Rosso JQ; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():46-52. PubMed ID: 10492666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole.
    Graybill JR; Williams DM; Van Cutsem E; Drutz DJ
    Rev Infect Dis; 1980; 2(4):551-58. PubMed ID: 6255531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to diagnose and treat fungal infections in chronic prostatitis.
    Wise GJ; Shteynshlyuger A
    Curr Urol Rep; 2006 Jul; 7(4):320-8. PubMed ID: 16930504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.